ARCHIVES

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

High Cervical Cancer Rates Indicate Access Problems

August 26, 2005

Seattle Times, The Hutch Duel Over Five-Part Series.

March 23, 2001

NCI SBIR Offers $10 million in 10 Awards

February 18, 2011

NCI To Fund 840 Competing Grants In FY 1991; No Downward Negotiations, But Careful Review

December 7, 1990

NCCN’s First Physician CEO: Robert Carlson Pledges Broader Research and Policy Agenda

October 5, 2012

Conference Explores Hype And Hope In Communicating Science News

May 15, 1998